Web Golinkin Joins Babson Diagnostics as President, CCO

Babson Diagnostics has appointed Web Golinkin as president and chief commercial officer to lead the company’s commercial strategy for BetterWay blood testing. 

“Web’s passion for patient-focused health care, his proven entrepreneurial track record, and deep expertise in commercial strategy will be instrumental as we expand access to accurate and easy-to-use blood testing services across the U.S.,” Babson Diagnostics CEO David Stein said. “He will play a pivotal role in accelerating the company’s mission to make routine blood testing more accessible and convenient for everyone.”

Golinkin has been CEO of five healthcare companies over the past 35 years, including three he co-founded. His past leadership roles include America’s Health Network, the largest cable TV network devoted to health; RediClinic, one of the nation’s largest retail clinic operators; Health Dialog, a leading population health management company; and FastMed, one of the nation’s largest urgent care operators.

“I’m honored to join Babson Diagnostics at such an exciting time in its journey,” Golinkin stated. “The company’s technology and commitment to patient-friendly diagnostics is transformative. I look forward to helping BetterWay realize its potential to improve patient care and reduce healthcare costs.”

BetterWay is blood testing reimagined—patient-friendly fingertip collection with accurate lab results. One in three people skip blood testing due to anxiety, fear of needles, difficult venous access, or inconvenience. BetterWay enables blood testing without phlebotomy. This improves patient experience, increases adherence to testing, optimizes staffing efficiency, and advances health equity. BetterWay was developed by Babson Diagnostics, a science-first healthcare technology company that has become the global thought leader in the use of capillary blood for routine testing.